Nationwide hosts IAMERS forum on QMS in advance of FDA report

Shortly before the summer congressional recess, the U.S. Senate passed a bipartisan bill to reauthorize the FDA user fee programs. The Senate User Fee bill followed the House bill and was approved 94-1. President Trump’s spokesperson has announced that the president will sign the bill.

See the full story at DOTmed by clicking here.

 

This entry was posted in Government, Healthcare. Bookmark the permalink.

Comments are closed.